semaglutide and ckd in Diabetic Kidney Disease: Integrating Clinical Evidence with Mechanistic Insights Study: Semaglutide slowed progression of

GLP-1 agonist medications are becoming more popular

2

Rybelsus is a tablet form of semaglutide, the ingredient that is found in the injectables Ozempic and Wegovy

FDA has agreed to the primary endpoint expected to be utilized in Phase 3 - Data from two Phase 2 studies of avexitide in people with PBH demonstrated highly statistically significant reductions in severe hypoglycemic events, an endpoint supported by the FDA - Avexitide was generally well tolerated, with a favorable safety profile replicated across five clinical trials in people with PBH - Management to host conference call and webcast today at

However, it also turns out that interaction of GLP-1 agonists with receptors found on brain cells leads to feelings of satiety and reduced hunger

Passing gastrointestinal updates, including mild constipation, transient diarrhea, or brief bouts of bloating/acid reflux